Tyrosine kinase inhibitors for elderly chronic myeloid leukemia patients: a systematic review of efficacy and safety data.
about
Impact of age on efficacy and toxicity of nilotinib in patients with chronic myeloid leukemia in chronic phase: ENEST1st subanalysis.Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatmentTyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry.Association between insurance status at diagnosis and overall survival in chronic myeloid leukemia: A population-based study.The impact of comorbidity on health-related quality of life in elderly patients with chronic myeloid leukemia.Morphology and immunophenotyping issues in the integrated diagnosis of hematologic disorders of elderly patients.Trends in all-cause mortality among patients with chronic myeloid leukemia: a Surveillance, Epidemiology, and End Results database analysis.Trends in mortality from leukemia in Europe: an update to 2009 and a projection to 2012.
P2860
Q33890580-9E86D6C7-49DD-446E-ABC4-309CD36AE1DDQ36288815-24E547CB-0151-4CC7-8256-2803BBE956CCQ37098856-9624E069-CBB9-4388-A4E8-861F9D69B28AQ38808692-C7DB5C04-A952-4B76-81CC-3EAE96BEDDAEQ40346616-1EB7D44C-B05A-40D7-B1A6-DA290C0DB915Q42609619-D5CDEAB1-B695-4CA1-9692-95E4B7AE9501Q44695808-063351C4-EE24-454C-B4D5-C0E9DCFD1FECQ47817140-25256564-5C0A-402E-9814-887345341654
P2860
Tyrosine kinase inhibitors for elderly chronic myeloid leukemia patients: a systematic review of efficacy and safety data.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Tyrosine kinase inhibitors for ...... w of efficacy and safety data.
@ast
Tyrosine kinase inhibitors for ...... w of efficacy and safety data.
@en
Tyrosine kinase inhibitors for ...... w of efficacy and safety data.
@nl
type
label
Tyrosine kinase inhibitors for ...... w of efficacy and safety data.
@ast
Tyrosine kinase inhibitors for ...... w of efficacy and safety data.
@en
Tyrosine kinase inhibitors for ...... w of efficacy and safety data.
@nl
prefLabel
Tyrosine kinase inhibitors for ...... w of efficacy and safety data.
@ast
Tyrosine kinase inhibitors for ...... w of efficacy and safety data.
@en
Tyrosine kinase inhibitors for ...... w of efficacy and safety data.
@nl
P50
P1476
Tyrosine kinase inhibitors for ...... w of efficacy and safety data.
@en
P304
P356
10.1016/J.CRITREVONC.2012.01.001
P577
2012-01-27T00:00:00Z